Pfizer’s Cancer Research Selected for Feasibility Study under AMED Program; Applied Jointly with Mie Univ. and Other Partners

Pfizer Japan announced on October 11 that an R&D theme it submitted jointly with other parties has been selected for a feasibility study by the Japan Agency for Medical Research and Development’s (AMED) Acceleration of Transformative research for Medical innovation...read more